|Own your ow legal marijuana business||
Your guide to making money in the multi-billion dollar marijuana industry
|Carl Olsen's Marijuana Archive|
MEDICINAL USE OF MARIJUANA
620--12.1(204) Purpose. To establish a research program for the investigational medical use of marijuana. Nothing in these rules will preclude the use of any available dosage forms of marijuana or tetrahydrocannabinols.
620--12.2(204) Definitions. For the purpose
of these rules, the following terms shall have the meaning in
12.2(1) "Board" means the Iowa Board of Pharmacy Examiners.
12.2(2) "Drug control program administrator" or "administrator" means the executive secretary of the board or a person appointed by the board.
12.2(3) "Marijuana" means that substance as defined in section 204.101(16) Code of Iowa.
12.2(4) "Tetrahydrocannabinols." Isolated or synthetic equivalents of substances contained in the plant or resinous fibers of cannabis sp., and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity as defined in 104.204(4)"q" Code of Iowa or Part 1308.11(d)(20) Code of Federal Regulations Title 21 revised as of April 1, 1978.
12.2(5) "Physicians advisory group" shall mean a committee of at least three physicians organized by the board for the purpose of advising and counseling the board. This advice and counsel shall include the following areas:
a. Designation of diseases or symptomatic conditions to be treated with marijuana or tetrahydrocannabinols.
b. Recruitment and selection of qualified clinical investigators.
c. Assist in the preparation of a plan or protocol for the study which will meet FDA standards and approval.
12.3(1) Physicians who wish to participate as clinical investigators shall submit their names to the administrator for approval by the physicians advisory group. The administrator shall collect such data as is deemed necessary by the advisory group and as required by the Food and Drug Administration, Public Health Service, Department of Health, Education and Welfare.
12.3(2) The administrator, with approval of the board and the concurrence of the physicians advisory group, shall prepare and file a "Notice of Claimed Investigational Exemption for a New Drug" (FDA Form 1571) with the federal Food and Drug Administration, Department of Health, Education and Welfare.
12.3(3) Concurrent with federal approval of the "Notice of Claimed Investigational Exemption of New Drug" and thereafter, the administrator shall be responsible for insuring adherence to the approved protocol by all parties involved. The administrator shall make quarterly reports on the progress of the program to the board. The administrator shall be responsible for program compliance with all state and federal requirements.
12.3(4) Clinical investigators approved by the board will be registered in accordance with the provisions of section 204.302, Code of Iowa and with Part 1301.32(6) of Title 21 Code of Federal Regulations.
12.3(5) This research program will terminate on June 30, 1981, unless one or more of the following takes place:
a. Legislative action extends the time period.
b. Marijuana or tetrahydrocannabinols are removed from Schedule I of the Federal Controlled Substances Act (Part 1308.11, Title 21, CFR) and placed in a classification which would allow their legal medical use and distribution.
c. Termination of the FDA approval to conduct clinical investigations with marijuana.
These rules are intended to implement Acts of the Sixty-eighth General Assembly, First Session, Senate File 487.
Schaffer Library of Drug Policy
Major Studies of Drug and Drug Policy
Marihuana, A Signal of Misunderstanding - The Report of the US National Commission on Marihuana and Drug Abuse
Licit and Illicit Drugs
Short History of the Marijuana Laws
The Drug Hang-Up
Congressional Transcripts of the Hearings for the Marihuana Tax Act of 1937
Frequently Asked Questions About Drugs
Basic Facts About the Drug War
Charts and Graphs about Drugs
Information on Alcohol
Guide to Heroin - Frequently Asked Questions About Heroin
LSD, Mescaline, and Psychedelics
Drugs and Driving
Children and Drugs
Drug Abuse Treatment Resource List
American Society for Action on Pain
Let Us Pay Taxes
Marijuana Business News
Reefer Madness Collection
Medical Marijuana Throughout History
Drug Legalization Debate
Legal History of American Marijuana Prohibition
Marijuana, the First 12,000 Years
DEA Ruling on Medical Marijuana
Legal References on Drugs
GAO Documents on Drugs
Response to the Drug Enforcement Agency
|Drug Information Articles|
Taking a drug test:
How To Pass A Drug Test
Beat Drug Test
Pass Drug Test
Drug Screening Tests
Drug Addiction Treatment